Table 5 Improvement in patient-reported outcomes through 12months
Baseline | 3months | Change from baseline | % Change from baseline | P valuea | 6months | Change from baseline | % Change from baseline | P valuea | 12 months | Change from baseline | % Change from baseline | P value* | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MP | 50 423 ± 253 361 (119–1582) | 49 202 ± 202 170 (0–1011) | 49 221 ± 290 191 (−700, 1265) | 49 45.2 ± 57.9% 56.9% (−225–100%) | <.001 | 48 181 ± 209 107 (0–1011) | 48 244 ± 302 191 (−700, 1307) | 48 51.9 ± 59.8% 68.6% (−225–100%) | <.001 | 48 173 ± 200 85 (0–786) | 48 243 ± 296 217 (−343, 1543) | 48 53.8 ± 50.5% 72.3% (−103–100%) | <.001 |
SSS | 50 61.7 ± 16.9 60.9% (28.1–100%) | 50 31.7 ± 20.1 31.3% (0.0–93.8%) | 50 30.0 ± 22.2 31.3 (−18.8, 84.4) | 50 46.7% ± 32.8% 52.5% (−33.3–100%) | <.001 | 49 25.1 ± 19.3 18.8 (0.0–78.1) | 49 36.7 ± 22.6 37.5 (−6.3, 75.0) | 49 57.6 ± 31.4% 66.7% (−22.2–100%) | <.001 | 49 26.6 ± 24.0 21.9 (0.0–78.1) | 49 35.3 ± 26.9 37.5 (−18.8, 93.8) | 49 55.1 ± 41.0% 62.5% (−66.7–100%) | <.001 |
HRQOL | 49 34.3 ± 19.0 30.2 (0.0–73.3) | 49 76.4 ± 22.2 83.6 (5.2–100) | 49 42.1 ± 25.6 40.5 (−7.8, 95.7) | 49 336 ± 846% 123% (−11.1–5550%) | <.001 | 48 79.5 ± 22.7 85.3 (0.9–100) | 48 44.5 ± 26.7 45.3 (−5.2, 96.6) | 48 266 ± 475% 118% (−28.6–2800%) | <.001 | 48 80.7 ± 24.7 91.4 (0.9–100) | 48 45.7 ± 30.5 45.7 (−33.6, 96.6) | 48 277 ± 483% 127% (−54.2–2800%) | <.001 |